Abbott to invest €85 million in the expansion of its Sligo pharmaceutical manufacturing facility

Abbott to invest €85 million in the expansion of its Sligo pharmaceutical manufacturing facility

Up to 175 new jobs to be created

Sligo, 9th February 2012 - Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly skilled jobs. The expansion of the facility will be completed in 2014. The investment is supported by the Irish Government through IDA Ireland.

The expansion will provide additional space for manufacturing operations to support Abbott's future pharmaceutical pipeline in the key therapeutic areas of virology, oncology and nephrology and provide additional capacity in Abbott's global pharmaceutical manufacturing network. The new jobs that will be created will be highly skilled and include roles in engineering, quality, pharmaceutical science and other science-based areas. The majority of the jobs will be added during the construction phase and the remainder will come on stream post the completion of the expansion. In addition, construction employment will create up to 150 temporary jobs.

"Abbott has had a presence in Ireland for more than 65 years and began manufacturing in the country in 1974. Sligo is an important part of Abbott's pharmaceutical manufacturing network and we are pleased to expand it to support future production needs. The success of our Sligo facility is due to the dedication of its staff and management. This state-of-the-art expansion will enable us to produce innovative therapies that we expect will represent significant advances in the treatment of cancer, chronic kidney disease and viral infections," said Dr. Azita Saleki-Gerhardt, President, Global Pharmaceutical Operations, Abbott.

Speaking from New York today, Barry O'Leary, CEO of IDA Ireland welcomed the announcement saying, "Abbott Ireland is of key importance to Ireland's life sciences sector and contributes substantially to Ireland's export economy. It is part of a strong cluster of life sciences companies in the Northwest region, which is hugely important to the local economy."

"Abbott, with 13 manufacturing, commercial and shared services sites across the country, continues to go from strength to strength and employs nearly 4,000 people. I wish Abbott Ireland every success with this new venture and offer the continued support of IDA Ireland as the company further develops its Irish operations.

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries.

Abbott in Ireland
Abbott is one of Ireland's leading health care companies, employing almost 4,000 people. Abbott Ireland manufactures and markets a broad range of health care products including medical devices, and pharmaceutical, diagnostic and nutritional products. Abbott has eight manufacturing facilities located in Clonmel, Cootehill, Cork, Donegal, Longford and Sligo, and a third party manufacturing management operation in Sligo. It has commercial operations in Dublin and shared services in Dublin and Westport. Abbott has been operating in Ireland since 1946.

Abbott's news releases and other information are available on the company's websites at and

For further information
IDA Ireland
 Antoinette Tyrrell,
 Press and PR Executive,
 Tel: +353 (0) 1 603 4256
 Mob: +353 (0) 87 7572053

 Carmel Mulroy,
 Head of Public Affairs,
 Abbott Ireland,
 Mob: + 353 (0) 86 605 80 40
 E: [email protected]